Saltar al contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lenguaje
Todos los Campos
Título
Autor
Materia
Número de Clasificación
ISBN/ISSN
Etiqueta
Buscar
Avanzado
Karyotype is an independent pr...
Citar
Describir
Enviar este por Correo electrónico
Imprimir
Exportar Registro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enlace Permanente
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
Detalles Bibliográficos
Autores principales:
Moorman, A
,
Harrison, C
,
Buck, G
,
Richards, S
,
Secker-Walker, L
,
Martineau, M
,
Vance, G
,
Cherry, A
,
Higgins, R
,
Fielding, A
,
Foroni, L
,
Paietta, E
,
Tallman, MS
,
Wernik, P
,
Litzow, MR
,
Rowe, J
,
Goldstone, A
,
Dewald, G
Formato:
Conference item
Publicado:
2007
Existencias
Descripción
Ejemplares similares
Vista Equipo
Ejemplares similares
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
por: Moorman, A, et al.
Publicado: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
por: Moorman, A, et al.
Publicado: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
por: Moorman, A, et al.
Publicado: (2005)
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
por: Fielding, A, et al.
Publicado: (2010)
Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
por: Fielding, A, et al.
Publicado: (2010)